Freightos Ltd·4

Apr 29, 4:05 PM ET

Lange Udo 4

4 · Freightos Ltd · Filed Apr 29, 2026

Research Summary

AI-generated summary of this filing

Updated

Freightos (CRGO) Director Udo Lange Receives RSU Award

What Happened
Udo Lange, a director of Freightos Ltd (CRGO), was granted an additional 97,562 restricted stock units (RSUs) on April 28, 2026 as an amendment to a prior award. The RSUs were granted at $0.00 (no cash paid). Under the amended terms the total grant to Lange is 121,952 RSUs, which will settle into 121,952 ordinary shares over a four‑year annual vesting schedule (30,488 shares vest each year), with full settlement by July 28, 2029. This was an award/grant (transaction code A), not a purchase or sale.

Key Details

  • Transaction date: 2026-04-28; Form 4 filed 2026-04-29 (timely).
  • Reported grant: 97,562 RSUs added; total RSU grant now 121,952 RSUs. Grant value reported at $0.00 (no cash paid at grant).
  • Vesting: 121,952 RSUs vest and settle in four equal annual installments of 30,488 shares on each of the first four anniversaries of the original grant date (July 28, 2025) — fully vested by July 28, 2029.
  • Related prior terms: Previously 24,390 RSUs were scheduled to vest by July 28, 2026 plus indeterminable future, now replaced by the fixed additional 97,562 RSUs.
  • Other note: A separate RSU grant (subject to board‑meeting attendance) began vesting Oct 1, 2025 and vests quarterly through Oct 1, 2026 (see filing footnote).
  • Filing exhibits: Exhibit 24.1 Power of Attorney included.

Context

  • This is a grant/award of equity (A), not a market buy or sale; such awards are compensation, not a direct bullish/bearish trade by the insider.
  • The amendment replaced future, market‑priced potential awards with a fixed share amount now subject to multi‑year vesting.
  • No immediate sale or exercise occurred; the insider will receive underlying shares only as RSUs vest.

Insider Transaction Report

Form 4
Period: 2026-04-28
Lange Udo
Director
Transactions
  • Award

    Ordinary Shares

    [F1][F2][F3]
    2026-04-28+97,562121,952 total
Holdings
  • Ordinary Shares

    [F4]
    48,084
  • Ordinary Shares

    [F4][F5]
    15,432
  • Stock Option (right to buy)

    [F4]
    Exercise: $15.00From: 2028-07-28Exp: 2032-07-28Ordinary Shares (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    [F4]
    Exercise: $10.00From: 2028-07-28Exp: 2032-07-28Ordinary Shares (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    [F4]
    Exercise: $5.00From: 2028-07-28Exp: 2032-07-28Ordinary Shares (100,000 underlying)
    100,000
Footnotes (5)
  • [F1]The transaction reported in this row consists of an amendment to an existing grant of restricted shares units ("RSUs") to the Reporting Person, which amendment was approved by the Issuer's board of directors on April 28, 2026. Under the amended terms, the Reporting Person received a finite number of additional ordinary shares represented by RSUs currently, with an annual vesting schedule, instead of being entitled to receive indeterminable numbers of additional ordinary shares at later dates based on the market price of the Issuer's ordinary shares at such later dates.
  • [F2]Under the prior grant terms, the Reporting Person had been granted 24,390 ordinary shares represented by 24,390 RSUs that began vesting on July 28, 2025 and that were to vest (and settle for 24,390 underlying ordinary shares) on the one-year anniversary of the vesting commencement date (July 28, 2026) (in addition to indeterminable numbers of additional ordinary shares to be granted later). Under the revised grant terms, in lieu of those future grants, the Reporting Person received a finite, additional 97,562 ordinary shares currently, represented by 97,562 RSUs, such that the total grant has been set at 121,952 ordinary shares represented by 121,952 RSUs.
  • [F3]The subject 121,952 ordinary shares consist of shares underlying 121,952 RSUs that will vest and settle in equal annual installments, for 30,488 ordinary shares each, on the first four anniversaries of the original July 28, 2025 grant date, such that all 121,952 ordinary shares will be received by the Reporting Person by July 28, 2029.
  • [F4]There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  • [F5]The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on October 1, 2025 and that vest (and settle for underlying ordinary shares) equally on a quarterly basis (25% of the RSUs per quarter) such that all such RSUs will be vested by the one-year anniversary of the grant date (October 1, 2026). Vesting is subject to the Reporting Person's fulfilling minimum attendance requirements at meetings of the Issuer's board of directors.
Signature
/s/ Max Sitnick, Attorney-in-fact|2026-04-29

Documents

2 files